Latest articles:

Akorn, Inc. Responds To FDA Draft Guidance For Industry On Bioequivalence Recommendation For Vancomycin HCl
Akorn, Inc. (NASDAQ: AKRX) provided the following response regarding FDA’s draft guidance on vancomycin hydrochloride (HCl) capsules. The Food and Drug Administration (FDA) has posted draft guidance for establishing bioequivalence (BE) for vancomycin HCl capsules. More: continued here
Akorn, Inc. Responds To FDA Draft Guidance For Industry On Bioequivalence Recommendation For Vancomycin HCl...

No Change To Dispensing Doctor Arrangements: NPA Statement
Reacting to the news that Phil Hope Minister of State has announced in the House that there will be will be no change to the current arrangements on GPs dispensing medicines to their patients. John Turk, NPA Chief Executive, comments: “Its good that ministers have
No Change To Dispensing Doctor Arrangements: NPA Statement...

New Centre Launched Today To Spearhead UK Research In Synthetic Biology
Programming biological cells so that they behave like engineering parts is the focus of research at a new UK centre launched today, thanks to an £8 million grant from the Engineering and Physical Sciences Research Council (EPSRC). The new centre will focus on synthetic
New Centre Launched Today To Spearhead UK Research In Synthetic Biology...

Teva Announces Tentative Approval Of Generic Seroquel® Tablets
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted tentative approval for the Company’s Abbreviated New Drug Application (ANDA) to market its generic version of AstraZeneca’s antipsychotic agent Seroquel® (Quetiapine Fumarate) Tablets, Eq. 25 mg base, 50 mg base, 100
Teva Announces Tentative Approval Of Generic Seroquel® Tablets...

Publication Of Research On Use Of Umbilical Cord Blood In Growing Undifferentiated Embryonic Stem Cells
Proteonomix, Inc. (PINKSHEETS: PROT) announces the publication in Cloning and Stem Cells Journal Volume 10 No. 4, published on November 20, 2008 by Mary Ann Liebert, Inc., of an article entitled “Cells Derived from Human
Publication Of Research On Use Of Umbilical Cord Blood In Growing Undifferentiated Embryonic Stem Cells...

Reducing Infant Mortality Requires Health Coverage For Women Throughout Childbearing Years, Editorial Says
Baltimore’s high infant mortality rate is a “crisis that gets too little attention in part because the solution is so costly: ensuring that thousands of low-income women of childbearing age have consistent access to health care that would produce better birth outcomes,” a Baltimore Sun editorial states. More:
Reducing Infant Mortality Requires Health Coverage For Women Throughout Childbearing Years, Editorial Says...

Hayashi Legislation Prompts Court Ruling To Expand Access To Prenatal Care - California
The San Francisco Superior Court has struck down a state law requiring that low-income working women must have resided in California for at least six months before they can be eligible to receive prenatal and other medical care services through California’s Access for Infants and Mothers (AIM) insurance
Hayashi Legislation Prompts Court Ruling To Expand Access To Prenatal Care - California...

Clinical Practice Guideline For Smoking Cessation In A Public Antenatal Care Setting
The study assesses the effectiveness of a smoking cessation guideline relevant to the public maternity care settings with an accompanying implementation program throughout Queensland maternity hospitals. Despite high level evidence proving the effectiveness of smoking cessation programs, few Australian hospitals have adopted a systematic approach to
Clinical Practice Guideline For Smoking Cessation In A Public Antenatal Care Setting...

New Paradigm For Medicinal Chemistry Offered By International Public-Private Partnership
The Wellcome Trust has announced a £4.1 million investment in a new initiative to generate small molecule inhibitors - “chemical probes” - for 25 proteins involved in epigenetic signalling, and to release these probes into the public domain with no restriction on use. Early stage information sharing on
New Paradigm For Medicinal Chemistry Offered By International Public-Private Partnership...

Among Older Adults, Prescription And Over-the-Counter Medications Are Commonly Used Together
A survey suggests that nearly half of older adults in the U.S. use prescription and over-the-counter medications together, and that about 4 percent of older adults are potentially at risk of an adverse drug reaction because of an interaction between medications, according to a study in the
Among Older Adults, Prescription And Over-the-Counter Medications Are Commonly Used Together...